Cargando…

Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract

PURPOSE: The primary objective of the study was to investigate the possible inhibition of cataract formation by topical administration of caffeine using the galactosemic rat model. It was hypothesized that caffeine will do so by acting as scavenger of reactive oxygen species known to be generated un...

Descripción completa

Detalles Bibliográficos
Autores principales: Varma, Shambhu D., Kovtun, Svitlana, Hegde, Kavita
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002968/
https://www.ncbi.nlm.nih.gov/pubmed/21179241
_version_ 1782193816042733568
author Varma, Shambhu D.
Kovtun, Svitlana
Hegde, Kavita
author_facet Varma, Shambhu D.
Kovtun, Svitlana
Hegde, Kavita
author_sort Varma, Shambhu D.
collection PubMed
description PURPOSE: The primary objective of the study was to investigate the possible inhibition of cataract formation by topical administration of caffeine using the galactosemic rat model. It was hypothesized that caffeine will do so by acting as scavenger of reactive oxygen species known to be generated under hyperglycemic conditions. METHODS: Cataract was induced by feeding young rats a diet containing 24% galactose for a period of 25 days. A control group of such rats was treated with a placebo eye drop preparation containing hydroxy propyl methyl cellulose as a wetting agent. In the experimental group, the rats were treated with the above preparation mixed with 72 mM caffeine. RESULTS: Administration of caffeine eye drops was found to significantly inhibit the onset as well as the progress of cataract formation. By day 25 on the galactose diet, all the animals in the control group developed advanced white opacity spread over the entire area of the lens. In the caffeine group, the formation of such opacity remained strikingly inhibited. The lenses remained largely transparent. The transparency data paralleled the higher concentration of glutathione maintained by caffeine treatment. Its levels in the placebo group were 0.8, 0.5, and 0.4 µmoles/g lens wt. on days 5, 15, and 25 against a consistent basal control value of ~3 µmoles/g over the entire period. In the caffeine group, the corresponding values were nearly 3 µmoles/g till day 15, but decreasing to ~2 µmoles/g on day 25. The levels were hence significantly higher than in the caffeine untreated group, remaining relatively closer to the basal controls. In addition, the compound was found effective in inhibiting morphological changes induced by galactose. CONCLUSIONS: Micromolar amounts of topical caffeine have been found to be significantly effective in inhibiting the formation of galactose cataract, strongly suggesting its possible usefulness against diabetic cataracts. The effects are attributed to its ability to prevent oxidative stress and consequent maintenance of tissue metabolic and transport functions, in addition to preventing the induction of apoptosis.
format Text
id pubmed-3002968
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-30029682010-12-22 Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract Varma, Shambhu D. Kovtun, Svitlana Hegde, Kavita Mol Vis Research Article PURPOSE: The primary objective of the study was to investigate the possible inhibition of cataract formation by topical administration of caffeine using the galactosemic rat model. It was hypothesized that caffeine will do so by acting as scavenger of reactive oxygen species known to be generated under hyperglycemic conditions. METHODS: Cataract was induced by feeding young rats a diet containing 24% galactose for a period of 25 days. A control group of such rats was treated with a placebo eye drop preparation containing hydroxy propyl methyl cellulose as a wetting agent. In the experimental group, the rats were treated with the above preparation mixed with 72 mM caffeine. RESULTS: Administration of caffeine eye drops was found to significantly inhibit the onset as well as the progress of cataract formation. By day 25 on the galactose diet, all the animals in the control group developed advanced white opacity spread over the entire area of the lens. In the caffeine group, the formation of such opacity remained strikingly inhibited. The lenses remained largely transparent. The transparency data paralleled the higher concentration of glutathione maintained by caffeine treatment. Its levels in the placebo group were 0.8, 0.5, and 0.4 µmoles/g lens wt. on days 5, 15, and 25 against a consistent basal control value of ~3 µmoles/g over the entire period. In the caffeine group, the corresponding values were nearly 3 µmoles/g till day 15, but decreasing to ~2 µmoles/g on day 25. The levels were hence significantly higher than in the caffeine untreated group, remaining relatively closer to the basal controls. In addition, the compound was found effective in inhibiting morphological changes induced by galactose. CONCLUSIONS: Micromolar amounts of topical caffeine have been found to be significantly effective in inhibiting the formation of galactose cataract, strongly suggesting its possible usefulness against diabetic cataracts. The effects are attributed to its ability to prevent oxidative stress and consequent maintenance of tissue metabolic and transport functions, in addition to preventing the induction of apoptosis. Molecular Vision 2010-12-08 /pmc/articles/PMC3002968/ /pubmed/21179241 Text en Copyright © 2010 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Varma, Shambhu D.
Kovtun, Svitlana
Hegde, Kavita
Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract
title Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract
title_full Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract
title_fullStr Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract
title_full_unstemmed Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract
title_short Effectiveness of topical caffeine in cataract prevention: Studies with galactose cataract
title_sort effectiveness of topical caffeine in cataract prevention: studies with galactose cataract
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002968/
https://www.ncbi.nlm.nih.gov/pubmed/21179241
work_keys_str_mv AT varmashambhud effectivenessoftopicalcaffeineincataractpreventionstudieswithgalactosecataract
AT kovtunsvitlana effectivenessoftopicalcaffeineincataractpreventionstudieswithgalactosecataract
AT hegdekavita effectivenessoftopicalcaffeineincataractpreventionstudieswithgalactosecataract